Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT03981471
Recruiting Not applicable

Fall Prevention in Elderly: Mechanisms and Strategies

NCT03981471 · tracked via the Priya Life Science China tracker
Sponsor
National Research Center for Rehabilitation Technical Aids
Phase
Not applicable
Started
2019-06-03
Last updated
2025-05-22

Condition(s) studied

Elderly

Investigational drug(s) / intervention(s)

Exercise

Exercise: Elderly people with or without fall history receive exercise to improve balance. Exercise interevention will be given 6 months in 2020. Outcomes (incidence of fall and biological tests) between two arms will be compared.

Study summary

In communities with over 100,000 residents, to investigate the incidence and mechanisms of fall in elderly, and strategies of fall prevention.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
Accepted
Inclusion Criteria: * community dwelling adults without medical conditions to impair walking ability Exclusion Criteria: * cognitively or physically unable to cooperate with the examiner to finish the test

Primary outcome measure(s)

  • Incidence of fall — From date of recruitment until the end of the study, assessed up to 42 months (reported once per year)
    Incidence of fall each year

Trial sites (2)

FacilityCityRegionStatus
National Research Center for Rehabilitation Technical Aids Beijing Beijing Municipality Not Yet Recruiting
National Research Center for Rehabilitation Technical Aids Beijing China Recruiting

More National Research Center for Rehabilitation Technical Aids trials in China

Neural Mechanisms of Cognitive Assessment and Rehabilitation for Cognitive Decline Recruiting
Developing Effectiveness Evaluation and Therapeutic Programs of Rehabilitation Recruiting

Other trials for the same condition

Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia Recruiting
AI-Based Risk Factor Analysis and Prediction Model of MACE in Elderly Hip Fracture Patients Postoperatively Active, not recruiting
The Influence of Standardized Process Management of Laryngeal Mask Airway Placement Based on Pressure Monitoring on the Incidence of Adverse Reactions in Elderly Patients During the Perioperative Period Recruiting
The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment Recruiting
Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03981471 on ClinicalTrials.gov ↗ ← All trials in China